Patent ID: 7037651

Claim:
A genetic testing method for systemic lupus erythematosus (SLE) in a human subject, comprising: a) collecting a tissue sample from a human subject; b) amplifying nucleic acids from said tissue sample to obtain amplification products, said nucleic acids comprising a genomic sequence of human chromosome 1 between microsatellite markers D1S2860 and D1S213; and c) detecting in the amplification products the presence or absence of a twelve-fold CA dinucleotide repeat sequence consisting of (SEQ. ID. NO.:6) located between said microsatellite markers D1S2860 and D1S213, wherein the presence of said twelve-fold CA dinucleotide repeat is diagnostic of SLE in a subject having SLE symptoms or indicates a genetic predisposition to develop SLE in a subject not presenting SLE symptoms.